iSpecimen Inc. (ISPC)
NASDAQ: ISPC · IEX Real-Time Price · USD
0.319
+0.033 (11.58%)
At close: Jul 11, 2024, 4:00 PM
0.347
+0.028 (8.71%)
Pre-market: Jul 12, 2024, 6:28 AM EDT

iSpecimen Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year
20232022202120202019
Revenue
9.9310.411.148.184.3
Revenue Growth (YoY)
-4.56%-6.58%36.06%90.40%-
Cost of Revenue
4.824.765.253.592.13
Gross Profit
5.115.655.894.62.17
Selling, General & Admin
9.8910.388.044.183.35
Research & Development
3.572.661.841.470.99
Other Operating Expenses
2.822.81.98-0.891.71
Operating Expenses
16.2815.8311.864.766.05
Operating Income
-11.17-10.19-5.97-0.16-3.88
Interest Expense / Income
0.020.242.12.11.72
Other Expense / Income
-0.09-0.180.892.39-0.72
Pretax Income
-11.1-10.25-8.96-4.65-4.88
Income Tax
0000-0.16
Net Income
-11.1-10.25-8.96-4.65-4.73
Shares Outstanding (Basic)
99411
Shares Outstanding (Diluted)
99411
Shares Change
2.23%106.28%357.95%0.01%-
EPS (Basic)
-1.23-1.16-2.09-4.97-5.05
EPS (Diluted)
-1.23-1.16-2.09-4.97-5.05
Free Cash Flow
-10.55-9.01-11.71-1.39-4.16
Free Cash Flow Per Share
-1.17-1.02-2.73-1.49-4.44
Gross Margin
51.45%54.27%52.86%56.19%50.49%
Operating Margin
-112.50%-97.92%-53.61%-1.96%-90.27%
Profit Margin
-111.80%-98.50%-80.48%-56.84%-109.97%
Free Cash Flow Margin
-106.28%-86.60%-105.13%-17.00%-96.67%
EBITDA
-9.02-8.8-5.86-1.74-2.52
EBITDA Margin
-90.83%-84.61%-52.58%-21.21%-58.73%
Depreciation & Amortization
2.071.2110.820.63
EBIT
-11.08-10.01-6.86-2.56-3.16
EBIT Margin
-111.64%-96.20%-61.60%-31.22%-73.51%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).